4 years ago

Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial

R. C. Y. Hui, C. C. Chi, L. C. See, Y. H. Huang, Y. K. Lin
Background Indigo naturalis and its refined formulation, Lindioil, are effective in treating psoriatic symptoms topically. Indirubin is the active ingredient in indigo naturalis. Objectives To determine the efficacy and safety of different concentrations of indirubin in Lindioil ointment for treating psoriasis. Methods In this randomized, double-blind trial, adult patients presenting with chronic plaque psoriasis for >1 year and with <20% of the body surface area (BSA) affected were randomized to apply Lindioil ointment containing 200 μg/g, 100 μg/g, 50 μg/g, or 10 μg/g of indirubin twice daily for 8 weeks followed by an additional 12-week safety/extension period. The primary endpoint was the mean percentage change in Psoriasis Area and Severity Index (PASI) score along with the proportion of subjects achieving 75% and 90% reductions in PASI scores (PASI75 and PASI90, respectively) from baseline to week 8. Results The results from week 8 revealed that the 200 μg/g group had the greatest reduction in PASI score (69·2%, 95% confidence interval [CI] 82·8–55·5), followed by the 100 μg/g group (63·1%, 95% CI 73·5–52·8), the 10 μg/g group (53·4%, 95% CI 64·0–42·8), and the 50 μg/g group (50·3%, 95% CI 63·2–37·4), with between-group comparison of P = 0·0445). The highest proportion of the subjects in the 200 μg/g group achieved PASI75 (56·5%, P = 0·0474) and PASI90 (30·4%, P = 0·0098). No severe treatment-related adverse events were reported during the 20-week evaluation. Conclusions 200 μg/g of indirubin in Lindioil ointment is the most effective concentration studied so far for treating psoriasis topically, and is safe ClinicalTrials . gov Identifier: NCT01735864 This article is protected by copyright. All rights reserved.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/bjd.15894

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.